Mednax Company Profile (NYSE:MD)

About Mednax

MEDNAX, Inc. is a provider of physician services, including newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. The Company's national network consists of approximately 3,240 affiliated physicians, including approximately 1,100 physicians who provide neonatal clinical care, in over 30 states and Puerto Rico, within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. It has over 250 affiliated physicians who provide maternal-fetal care to expectant mothers experiencing complicated pregnancies and obstetrical hospitalist services in many areas where its affiliated neonatal physicians practice. Its physician specialties and services include neonatal care, anesthesia and anesthesia subspecialty care, pain management, maternal-fetal care, pediatric cardiology care, and other pediatric subspecialty care. It also offers revenue cycle management and consulting services.

Industry, Sector and Symbol:

Sector: Medical
Industry: Specialized Health Services
Sub-Industry: Health Care Services
Exchange: NYSE
Symbol: MD
CUSIP: 58502B10

Key Metrics:

Previous Close: $65.11
50 Day Moving Average: $65.36
200 Day Moving Average: $68.20
52-Week Range: $61.40 - $83.20
Trailing P/E Ratio: 18.26
Foreward P/E Ratio: 14.41
P/E Growth: 1.08
Market Cap: $6.03B
Outstanding Shares: 92,181,000
Beta: 0.56

Profitability:

Net Margins: 11.17%
Return on Equity: 14.88%
Return on Assets: 7.87%

Debt:

Debt-to-Equity Ratio: 0.56%
Current Ratio: 1.65%
Quick Ratio: 1.65%

Additional Links:

Companies Related to Mednax:

Consensus Ratings for Mednax (NYSE:MD) (?)

Ratings Breakdown:	3 Hold Ratings, 6 Buy Ratings
Consensus Rating:	Buy (Score: 2.67)
Consensus Price Target:	$75.63 (14.60% upside)

Analysts' Ratings History for Mednax (NYSE:MD)

Show:

Date	Firm	Action	Rating	Price Target
9/20/2016	Mizuho	Reiterated Rating	Buy	$79.00
8/26/2016	Jefferies Group	Lower Price Target	Buy	$80.00 -> $75.00
8/17/2016	Citigroup Inc.	Lower Price Target	Neutral	$76.00 -> $72.00
7/29/2016	JPMorgan Chase & Co.	Lower Price Target	Overweight	$85.00 -> $80.00
5/16/2016	Robert W. Baird	Reiterated Rating	Buy
3/14/2016	Piper Jaffray Cos.	Reiterated Rating	Overweight	$76.00
3/8/2016	Stifel Nicolaus	Lower Price Target	Buy	$81.00 -> $76.00
3/7/2016	Susquehanna	Downgrade	Positive -> Neutral	$94.00 -> $70.00
12/2/2015	Stephens	Reiterated Rating	Equal Weight	$77.00
9/20/2015	William Blair	Reiterated Rating	Buy
7/31/2015	Dougherty & Co	Boost Price Target	Buy	$88.00 -> $90.00
5/23/2015	Deutsche Bank AG	Reiterated Rating	Buy	$77.00 -> $79.00
5/13/2015	Raymond James Financial Inc.	Boost Price Target	Outperform	$78.00 -> $80.00

(Data available from 9/28/2014 forward)

Earnings History for Mednax (NYSE:MD)

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
10/27/2016
7/28/2016	Q216	$1.07	$1.03	$775.68 million	$772.00 million	View	Listen
4/28/2016	Q116	$0.86	$0.87	$741.49 million	$752.60 million	View	Listen
2/4/2016	Q415	$1.10	$1.13	$748.02 million	$742.00 million	View	Listen
10/29/2015	Q315	$0.97	$1.10	$730.63 million	$722.30 million	View	Listen
7/30/2015	Q215	$0.88	$0.90	$677.02 million	$676.60 million	View	Listen
4/30/2015	Q115	$0.71	$0.72	$641.24 million	$639.40 million	View	Listen
1/29/2015	Q414	$0.86	$0.89	$637.90 million	$651.00 million	View	Listen
10/30/2014	Q314	$0.85	$0.86	$619.61 million	$627.00 million	View	Listen
7/31/2014	Q214	$0.78	$0.79	$603.00 million	$595.54 million	View	Listen
5/1/2014	Q114	$0.63	$0.63	$574.80 million	$566.00 million	View	Listen
1/30/2014	Q4	$0.75	$0.20	$555.30 million	$567.00 million	View	Listen
10/31/2013	Q313	$1.48	$1.52	$556.63 million	$555.00 million	View	Listen
7/30/2013	Q2 2013	$1.36	$1.37	$533.39 million	$529.18 million	View	Listen
5/2/2013	Q1 2013	$1.09	$1.10	$504.24 million	$502.70 million	View	Listen
1/31/2013	Q4 2012	$1.30	$1.32	$473.70 million	$471.30 million	View	Listen
11/1/2012	Q312	$1.28	$1.32	$470.60 million	$473.10 million	View	N/A
7/31/2012		$1.19	$1.22			View	N/A
5/3/2012		$1.00	$0.98			View	N/A
2/2/2012		$1.19	$1.19			View	N/A
11/1/2011		$1.18	$1.19			View	N/A
8/2/2011		$1.15	$1.15			View	N/A
5/3/2011		$0.91	$0.94			View	N/A
2/3/2011		$1.12	$1.12			View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Mednax (NYSE:MD)

Current Year EPS Consensus Estimate: $4.14 EPS
Next Year EPS Consensus Estimate: $4.58 EPS

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q3 2016	3	$1.04	$1.05	$1.05
Q4 2016	3	$1.05	$1.09	$1.07

(Data provided by Zacks Investment Research)

Dividend History for Mednax (NYSE:MD)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Mednax (NYSE:MD)

Insider Ownership Percentage: 2.40%
Institutional Ownership Percentage: 97.75%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
9/14/2016	Md Pascal J Goldschmidt	Director	Sell	1,500	$65.01	$97,515.00
6/13/2016	Dominic J Andreano	SVP	Sell	3,922	$68.80	$269,833.60
6/8/2016	Md Carlo A Waldemar	Director	Sell	5,334	$70.50	$376,047.00
6/7/2016	Karl B Wagner	Insider	Sell	27,482	$68.45	$1,881,142.90
6/1/2016	Joseph M Calabro	COO	Sell	28,347	$67.78	$1,921,359.66
6/1/2016	Michael D Stanley	Insider	Sell	14,778	$67.78	$1,001,652.84
5/16/2016	Dominic J Andreano	SVP	Sell	3,000	$68.53	$205,590.00
5/2/2016	Vivian Lopez-Blanco	CFO	Sell	9,350	$71.22	$665,907.00
3/11/2016	Md Pascal J Goldschmidt	Director	Sell	3,100	$65.00	$201,500.00
2/29/2016	Paul G Gabos	Director	Sell	10,668	$67.15	$716,356.20
12/11/2015	Md Pascal J. Goldschmidt	Director	Sell	5,250	$70.99	$372,697.50
9/8/2015	Cesar L. Alvarez	Director	Sell	10,668	$81.00	$864,108.00
8/27/2015	Roger Md Medel	CEO	Sell	100,000	$80.27	$8,027,000.00
6/8/2015	Karl B Wagner	Insider	Sell	37,820	$70.28	$2,657,989.60
6/3/2015	Joseph M Calabro	COO	Sell	108,071	$70.51	$7,620,086.21
3/9/2015	Md Pascal J Goldschmidt	Director	Sell	8,500	$71.25	$605,625.00
2/26/2015	Roger Md Medel	CEO	Sell	100,000	$71.61	$7,161,000.00
2/20/2015	Md Carlo A Waldemar	Director	Sell	10,668	$71.50	$762,762.00
2/6/2015	Dominic J Andreano	SVP	Sell	3,200	$70.75	$226,400.00
2/6/2015	Vivian Lopez-Blanco	CFO	Sell	8,250	$69.95	$577,087.50
2/2/2015	Paul G Gabos	Director	Sell	17,584	$68.07	$1,196,942.88
1/30/2015	William C Hawk	COO	Sell	3,598	$68.50	$246,463.00
11/14/2014	Roger Md Medel	CEO	Sell	51,290	$62.59	$3,210,241.10
11/13/2014	Roger Md Medel	CEO	Sell	63,440	$62.55	$3,968,172.00
11/7/2014	Roger Md Medel	CEO	Sell	128,833	$62.60	$8,064,945.80
11/5/2014	Roger Md Medel	CEO	Sell	169,845	$62.60	$10,632,297.00
11/4/2014	Roger Md Medel	CEO	Sell	15,052	$62.52	$941,051.04
11/3/2014	Roger Md Medel	CEO	Sell	10,881	$62.52	$680,280.12
10/31/2014	Roger Md Medel	CEO	Sell	61,592	$62.58	$3,854,427.36
10/30/2014	Karl B Wagner	Insider	Sell	40,000	$62.50	$2,500,000.00
10/30/2014	Vivian Lopez-Blanco	CFO	Sell	8,800	$60.00	$528,000.00
7/30/2014	Karl B Wagner	Insider	Sell	80,000	$60.00	$4,800,000.00
6/10/2014	Dominic J Andreano	SVP	Sell	2,252	$58.48	$131,696.96
6/6/2014	Karl B Wagner	Insider	Sell	44,596	$58.53	$2,610,203.88
6/5/2014	William C Hawk	COO	Sell	6,911	$57.66	$398,488.26
6/2/2014	David A Clark	COO	Sell	16,230	$57.00	$925,110.00
6/2/2014	Michael D Stanley	Insider	Sell	18,006	$57.00	$1,026,342.00
5/9/2014	Karl Wagner	Insider	Sell	79,524	$57.09	$4,540,025.16
5/9/2014	Md Pascal Goldschmidt	Director	Sell	30,000	$57.11	$1,713,300.00
5/8/2014	Joseph Calabro	COO	Sell	137,500	$57.06	$7,845,750.00
2/20/2014	Dominic Andreano	SVP	Sell	3,000	$61.00	$183,000.00
2/10/2014	Joseph Calabro	COO	Sell	150,000	$55.55	$8,332,500.00
2/10/2014	Md Carlo Waldemar	Director	Sell	10,668	$55.40	$591,007.20
11/7/2013	Enrique Sosa	Director	Sell	5,334	$107.00	$570,738.00
11/7/2013	Karl Wagner	Insider	Sell	1,800	$107.60	$193,680.00
9/11/2013	William C Hawk	COO	Sell	3,162	$100.62	$318,160.44
9/10/2013	Dominic J Andreano	SVP	Sell	3,718	$99.63	$370,424.34
8/7/2013	Karl Wagner	Insider	Sell	25,000	$98.01	$2,450,250.00
8/2/2013	Joseph M Calabro	COO	Sell	36,154	$98.57	$3,563,699.78
6/3/2013	David A Clark	COO	Sell	8,645	$91.01	$786,781.45
6/3/2013	Michael D Stanley	Insider	Sell	8,906	$91.01	$810,535.06

(Data available from 1/1/2013 forward)

Latest Headlines for Mednax (NYSE:MD)

Date	Headline
	MEDNAX-Affiliated Anesthesiologist Receives First “Physician of Excellence” Designation in the United States by the ERAS ® Society (NYSE:MD) www.enhancedonlinenews.com - September 21 at 10:11 AM
	Sell-side Consensus Sees Mednax, Inc (NYSE:MD) Going Where Near-Term? - Frisco Fastball (NYSE:MD) friscofastball.com - September 20 at 11:14 AM
	MEDNAX, Inc. (NYSE:MD) earnings reaction history - The Independent Republic (NYSE:MD) theindependentrepublic.com - September 20 at 11:14 AM
	Shining Stocks in News Recap- MEDNAX, Inc. (NYSE:MD), Lexington Realty Trust (NYSE:LXP), Intel Corporation ... - Seneca Globe (NYSE:MD) www.senecaglobe.com - September 19 at 10:37 AM
	Mednax Inc (MD) Receives Anayst Rating (NYSE:MD) www.nationaldailypress.com - September 18 at 5:44 PM
	How Many MEDNAX Inc (NYSE:MD)'s Analysts Are Bullish? - Post News (NYSE:MD) www.kentuckypostnews.com - September 17 at 5:44 PM
	Form 4 MEDNAX, INC. For: Sep 14 Filed by: Goldschmidt, MD Pascal J - StreetInsider.com (NYSE:MD) www.streetinsider.com - September 17 at 5:44 PM
	Form 4 MEDNAX, INC. For: Sep 14 Filed by: Goldschmidt, MD Pascal J (NYSE:MD) www.streetinsider.com - September 16 at 5:53 PM
	MEDNAX (MD) Makes Two Acquisitions in Florida, South Carolina (NYSE:MD) www.streetinsider.com - September 16 at 9:44 AM
	MEDNAX Announces Acquisitions of Anesthesiology Practices in South Carolina and Florida (NYSE:MD) www.publicnow.com - September 16 at 9:44 AM
	Rainier Investment Management buys $25240110 stake in MEDNAX Inc (MD) - National Daily Press (NYSE:MD) www.nationaldailypress.com - September 11 at 10:14 AM
	Rainier Investment Management buys $25,240,110 stake in MEDNAX Inc (MD) (NYSE:MD) www.nationaldailypress.com - September 9 at 5:50 PM
	Shares Higher Over the Last Five Trading Sessions: MEDNAX, Inc. (NYSE:MD) - Post News (NYSE:MD) www.kentuckypostnews.com - September 6 at 6:07 PM
	Analysts Valuations For Two Stocks: Steel Dynamics, Inc. (NASDAQ:STLD), MEDNAX Inc (NYSE:MD) - The Voice Registrar (NYSE:MD) voiceregistrar.com - August 30 at 6:04 PM
	ETF’s with exposure to MEDNAX, Inc. : August 30, 2016 (NYSE:MD) www.capitalcube.com - August 30 at 6:04 PM
	Stock Up Over the Past Five Trading Days: MEDNAX, Inc. (NYSE:MD) - Post News (NYSE:MD) www.kentuckypostnews.com - August 30 at 9:26 AM
	MEDNAX to Present at the Baird 2016 Global Healthcare Conference (NYSE:MD) finance.yahoo.com - August 30 at 9:26 AM
	Watch for Mednax to Potentially Rebound After Falling 1.16% Yesterday (NYSE:MD) www.mysmartrend.com - August 25 at 6:02 PM
	Mawer Investment Management Ltd. Buys A Little More Mednax, Inc. Common Stock (MD) Stock In The Last Quarter (NYSE:MD) www.fidaily.com - August 17 at 6:18 PM
	MEDNAX (MD) Acquires Maternal-Fetal Practice in Florida (NYSE:MD) www.zacks.com - August 16 at 9:24 AM
	MEDNAX (MD) Acquires Anesthesiology Practice in Nevada (NYSE:MD) finance.yahoo.com - August 15 at 6:18 PM
	MEDNAX (MD) Acquires Florida-Based Maternal Fetal Medicine (NYSE:MD) www.streetinsider.com - August 15 at 8:17 AM
	6:46 am MEDNAX announces acquisition of Maternal Fetal Medicine of Southwest Florida (NYSE:MD) finance.yahoo.com - August 15 at 8:17 AM
	MEDNAX Announces Acquisition of Maternal-Fetal Medicine Practice in Florida (NYSE:MD) www.publicnow.com - August 15 at 8:17 AM
	BRIEF-Mednax acquires Maternal-Fetal Medicine Practice in Florida (NYSE:MD) feeds.reuters.com - August 15 at 7:33 AM
	Which way MEDNAX (NYSE:MD) earnings may go - The Voice Registrar (NYSE:MD) voiceregistrar.com - August 12 at 6:11 PM
	ETF’s with exposure to MEDNAX, Inc. : August 11, 2016 (NYSE:MD) www.capitalcube.com - August 11 at 6:26 PM
	Palisade Capital Managementnj buys $38,968,224 stake in MEDNAX Inc (MD) (NYSE:MD) www.tradecalls.org - August 9 at 6:21 PM
	MEDNAX, INC. Files SEC form 8-K, Change in Directors or Principal Officers (NYSE:MD) biz.yahoo.com - August 9 at 6:21 PM
	MEDNAX (MD) Acquires Nevada-Based Anesthesiology Practice (NYSE:MD) www.streetinsider.com - August 9 at 9:13 AM
	Edgemont Capital Partners Completes Sale of Associated Anesthesiologists of Reno to MEDNAX (NYSE:MD) www.tmcnet.com - August 8 at 6:19 PM
	MEDNAX Inc.: MEDNAX Announces Acquisition of Anesthesiology Practice in Nevada (NYSE:MD) www.twst.com - August 8 at 10:47 AM
	MEDNAX Announces Acquisition of Anesthesiology Practice in Nevada (NYSE:MD) www.publicnow.com - August 8 at 10:47 AM
	Riverbridge Partners Lowers stake in MEDNAX Inc (MD) - Trade Calls (NYSE:MD) www.tradecalls.org - August 5 at 6:19 PM
	MEDNAX, Inc. :MD-US: Earnings Analysis: Q2, 2016 By the Numbers : August 4, 2016 (NYSE:MD) www.capitalcube.com - August 4 at 6:27 PM
	MEDNAX, INC. Financials (NYSE:MD) finance.yahoo.com - August 4 at 6:27 PM
	Stock's Earnings Activity: MEDNAX, Inc. (NYSE:MD), ResMed Inc. (NYSE:RMD) - News Oracle (NYSE:MD) www.newsoracle.com - August 2 at 6:24 PM
	Earnings Miss Presents Buying Opportunity For Mednax - Mednax ... - Seeking Alpha (NYSE:MD) seekingalpha.com - July 31 at 5:43 PM
	MEDNAX Inc (NYSE:MD) Under The Radar Analyst Recommendations - The Voice Registrar (NYSE:MD) voiceregistrar.com - July 30 at 8:57 AM
	National-Oilwell Varco, (NYSE:NOV) & MEDNAX Inc (NYSE:MD) Investor's Watch List - Money News (press release) (NYSE:MD) www.newsismoney.com - July 30 at 8:57 AM
	Considerable Healthcare Losers- MEDNAX, Inc. (NYSE:MD), NovoCure Limited (NASDAQ:NVCR) - Seneca Globe (NYSE:MD) www.senecaglobe.com - July 30 at 8:57 AM
	Mednax Inc. (MD) is Trading Lower on Unusual Volume for July 28 - Equities.com (NYSE:MD) www.equities.com - July 30 at 8:57 AM
	Edited Transcript of MD earnings conference call or presentation 28-Jul-16 2:00pm GMT (NYSE:MD) finance.yahoo.com - July 29 at 4:38 PM
	MEDNAX, Inc. breached its 50 day moving average in a Bearish Manner : MD-US : July 29, 2016 (NYSE:MD) www.capitalcube.com - July 29 at 8:30 AM
	MEDNAX Inc Earnings Call scheduled for 10:00 am ET today (NYSE:MD) biz.yahoo.com - July 28 at 10:00 AM
	MEDNAX, Inc. (NYSE:MD) Earnings Preview: Should Investors Be Nervous? - The Voice Registrar (NYSE:MD) voiceregistrar.com - July 28 at 9:20 AM
	Q2 2016 MEDNAX Inc Earnings Release - Before Market Open (NYSE:MD) biz.yahoo.com - July 28 at 7:07 AM
	MEDNAX, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NYSE:MD) biz.yahoo.com - July 28 at 6:52 AM
	MEDNAX Reports Second Quarter GAAP EPS of $0.89; Adjusted EPS of $1.03 (NYSE:MD) www.publicnow.com - July 28 at 6:18 AM
	Mednax misses Street 2Q forecasts (NYSE:MD) sg.finance.yahoo.com - July 28 at 6:13 AM